Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series — Flora Zagouri (2013) | RDL Network
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
Article 2013 en
Authors
FZ
Flora Zagouri
TS
Theodoros Ν. Sergentanis
VK
Vassilis Koutoulidis
Abstract
1 min read
Our study shows that AIs with or without GnRH analogues may represent an effective and safe treatment option for hormone-receptor positive, pretreated, metastatic, male breast cancer patients.
Renée T. Fortner, Danja Sarink, Helena Schöck, Theron Johnson, Anne Tjønneland, Anja Olsen, Kim Overvad, Aurélie Affret, Mathilde His, Marie‐Christine Boutron‐Ruault, Heiner Boeing, Antonia Trichopoulou, Androniki Naska, Philippos Orfanos, Domenico Palli, Sabina Sieri, Amalia Mattiello, Rosario Tumino, Fulvio Ricceri, H. Bas Bueno‐de‐Mesquita, Petra H. Peeters, Carla H. van Gils, Elisabete Weiderpass, Eiliv Lund, J. Ramón Quirós, Antonio Agudo, María‐José Sánchez, María-Dolores Chirlaque, Eva Ardanáz, Miren Dorronsoro, Tim Key, Kay‐Tee Khaw, Sabina Rinaldi, Laure Dossus, Marc J. Gunter, Melissa A. Merritt, Elio Riboli, Rudolf Kaaks
Discussion(0)
No comments yet. Be the first to comment.